Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate (Q43016412)

12 November 2017

Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate (English)

1 reference

12 November 2017

1 reference

4

Helena Gil-Peña

1 reference

12 November 2017

Oscar Alvarez-García

1

1 reference

12 November 2017

Enrique García-López

2

1 reference

12 November 2017

Vanessa Loredo

3

1 reference

12 November 2017

Julián Rodríguez-Suárez

5

1 reference

12 November 2017

Flor A Ordóñez

6

1 reference

12 November 2017

Eduardo Carbajo-Pérez

7

1 reference

12 November 2017

Fernando Santos

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

16 June 2010

1 reference

12 November 2017

1 reference

12 November 2017

78

1 reference

12 November 2017

6

1 reference

12 November 2017

561-568

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.173

12 November 2017

0 references

cites work

Clinical application of sirolimus in renal transplantation: an update

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Upstream and downstream of mTOR

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Sirolimus to replace calcineurin inhibitors? Too early yet.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Sirolimus in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Rapamycin retards growth and causes marked alterations in the growth plate of young rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Bone growth during rapamycin therapy in young rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

The effect of rapamycin on bone growth in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

mTOR-what does it do?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Systemic and local regulation of the growth plate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Rapamycin is an effective inhibitor of human renal cancer metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Mammalian Target of Rapamycin Inhibition Halts the Progression of Proteinuria in a Rat Model of Reduced Renal Mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Regulation of autophagy in human and murine cartilage: hypoxia-inducible factor 2 suppresses chondrocyte autophagy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Chondrocytes embedded in the epiphyseal growth plates of long bones undergo autophagy prior to the induction of osteogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.173

7 January 2021

Identifiers

DOI

10.1038/KI.2010.173

1 reference

Dimensions Publication ID

12 November 2017

1047971822

0 references

Fatcat ID

release_e5luzonnnrc3rpbossfbegxeam

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e5luzonnnrc3rpbossfbegxeam

24 November 2022

mapped directly with Wikidata item

1 reference